| Literature DB >> 73740 |
J Kohn, A H Orr, T J McElwain, M Bentall, M J Peckham.
Abstract
Serum-alpha1-fetoprotein (A.F.P.) was assayed in 88 men with testicular teratomas and 34 with seminomas. 61% of teratoma patients with clinically evident disease had serum-A.F.P. greater than 25 ng/ml, whilst it is highly unlikely that any patient with a pure seminoma had a titre above this level. A.F.P. concentrations correlated with response to radiotherapy and chemotherapy and predicted relapse in some patients. Serum-A.F.P. should be measured in all patients with testicular tumours.Entities:
Mesh：
Substances：
Year: 1976 PMID： 73740 DOI： 10.1016/s0140-6736(76)92524-1
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321